Cellavision

Overview

CellaVision is a Swedish company founded in 1994, specializing in the manufacturing of digital cell morphology solutions aimed at enhancing laboratory efficiency and accuracy in hematology. With an employee size ranging from 201 to 500, the company generates approximately $30 million in revenue. CellaVision's technology automates the analysis and review of blood samples, allowing hematology professionals to achieve consistent and accurate results. This is particularly beneficial in environments facing challenges such as heavy workloads, staff shortages, and the need for collaboration across distributed teams. For instance, the Vancouver Island Health Authority implemented CellaVision's systems to connect multiple laboratory sites, streamlining operations and improving service quality for clinicians and patients across a geographically dispersed network. The company's focus on digital solutions reflects its commitment to advancing laboratory practices and enhancing patient care through innovative technology. CellaVision's contributions are recognized in case studies that highlight the transformative impact of its products on laboratory workflows.

Industry